Patents by Inventor Yoshinobu Miyatsu

Yoshinobu Miyatsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10392603
    Abstract: A method of producing a virus in cell culture comprising at least the steps of a) providing a population of cells cultured in a cell culture medium, b) infecting the population of cells by i. inoculating the population with the virus, and ii. incubating the inoculated population so as to allow the virus to replicate and propagate, c) collecting the produced virus, thereby providing a viral harvest, and d) purifying the virus, wherein a power density of at least 15 W/m3, at least 30 W/m3, at least 60 W/m3, at least 100 W/m3, at least 120 W/m3 is applied to the cell culture at least during step b).
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: August 27, 2019
    Assignee: The Chemo-Sero-Therapeutic Research Institute
    Inventors: Pascal Charles Louis Gerkens, Michele Therese Rita Lecocq, Tatsuya Kasugaya, Kenjiro Kawatsu, Yoshinobu Miyatsu, Tetsuro Tanabe
  • Publication number: 20160208220
    Abstract: A method of producing a virus in cell culture comprising at least the steps of a) providing a population of cells cultured in a cell culture medium, b) infecting the population of cells by i. inoculating the population with the virus, and ii. incubating the inoculated population so as to allow the virus to replicate and propagate, c) collecting the produced virus, thereby providing a viral harvest, and d) purifying the virus, wherein a power density of at least 15 W/m3, at least 30 W/m3, at least 60 W/m3, at least 100 W/m3, at least 120 W/m3 is applied to the cell culture at least during step b).
    Type: Application
    Filed: August 28, 2014
    Publication date: July 21, 2016
    Inventors: Pascal Charles Louis GERKENS, Michele Therese Rita LECOCQ, Tatsuya KASUGAYA, Kenjiro KAWATSU, Yoshinobu MIYATSU, Tetsuro TANABE
  • Patent number: 7667009
    Abstract: A method for purifying a modified major mite allergen obtained by the genetic recombination technique and a purified modified major mite allergen obtained by said method for purification are provided.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: February 23, 2010
    Assignee: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Satoshi Koyanagi, Kenjiro Kawatsu, Toshio Murakami, Yoshinobu Miyatsu, Toshihiro Maeda, Hiroshi Mizokami
  • Patent number: 7531631
    Abstract: The present invention herein discloses a method for purifying human serum albumin, which is characterized in that it comprises the steps of heat-treating a human serum albumin-containing solution including impurities originated from a host cell, in the presence of a divalent cation such as calcium ion, magnesium ion, nickel ion, cobalt ion, iron ion and zinc ion to thus selectively allow the impurities to undergo agglutination. The present invention also provides the highly purified human serum albumin prepared by the foregoing method.
    Type: Grant
    Filed: July 20, 2006
    Date of Patent: May 12, 2009
    Assignee: Juridical Foundation the Chemoserotherapeutic Research Institute
    Inventors: Shinichi Shibata, Kazuyuki Nakashima, Tetsurou Tanabe, Yoshinobu Miyatsu, Hiroshi Mizokami
  • Publication number: 20080113424
    Abstract: A method for purifying a modified major mite allergen obtained by the genetic recombination technique and a purified modified major mite allergen obtained by said method for purification are provided.
    Type: Application
    Filed: April 14, 2004
    Publication date: May 15, 2008
    Applicant: Juridicical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Satoshi Koyanagi, Kenjiro Kawatsu, Toshio Murakami, Yoshinobu Miyatsu, Toshihiro Maeda, Hiroshi Mizokami
  • Publication number: 20070065906
    Abstract: A heterologous protein free from an inducer and a method for producing said protein are provided. A method for producing a heterologous protein which comprises the step of optionally culturing at low temperature recombinant E. coli cells expressing a heterologous protein under control of a promoter capable of inducing expression through temperature shift and then culturing at high temperature said recombinant E. coli cells in the absence of an inducer to thereby allow for expression of said heterologous protein, or the step of culturing at high temperature said recombinant E. coli cells to thereby simultaneously allow for both cell proliferation and expression of said heterologous protein, and the heterologous protein obtained by said method that is free from an inducer. Such heterologous protein may include a major mite allergen, a secretary macrophage toxin from Actinobacillus pleuropneumoniae and a surface protective antigen (SpaA) of Erysipelothrix rhusiopathiae.
    Type: Application
    Filed: February 20, 2004
    Publication date: March 22, 2007
    Applicant: JURIDICAL FOUNDATION the CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
    Inventors: Satoshi Koyanagi, Keishin Sugawara, Yoshinobu Miyatsu, Toshio Murakami, Toshihiro Maeda, Hiroshi Mizokami
  • Publication number: 20060258850
    Abstract: The present invention herein discloses a method for purifying human serum albumin, which is characterized in that it comprises the steps of heat-treating a human serum albumin-containing solution including impurities originated from a host cell, in the presence of a divalent cation such as calcium ion, magnesium ion, nickel ion, cobalt ion, iron ion and zinc ion to thus selectively allow the impurities to undergo agglutination. The present invention also provides the highly purified human serum albumin prepared by the foregoing method.
    Type: Application
    Filed: July 20, 2006
    Publication date: November 16, 2006
    Inventors: Shinichi Shibata, Kazuyuki Nakashima, Tetsurou Tanabe, Yoshinobu Miyatsu, Hiroshi Mizokami
  • Patent number: 7001885
    Abstract: Multimers of human serum albumin are removed from a solution of human serum albumin containing the multimers by bringing the human serum albumin solution into contact with an anion-exchanger equilibrated with a buffer containing a salt in a concentration ranging from 10 to 150 mM and having a pH value ranging from 5 to 9.5.
    Type: Grant
    Filed: June 20, 2002
    Date of Patent: February 21, 2006
    Assignee: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Satoshi Adachi, Hiroshi Mizokami, Yoshitaka Tajima, Yoshinobu Miyatsu, Toshinobu Nouchi, Yoshitaka Ushio
  • Patent number: 6908749
    Abstract: A method for preparing human serum albumin comprises the step of heat-treating a human serum albumin solution containing contaminants at a pH value in the proximity to the isoelectric point of the contaminants.
    Type: Grant
    Filed: June 20, 2002
    Date of Patent: June 21, 2005
    Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Toshinobu Nouchi, Hiroshi Mizokami, Yoshitaka Tajima, Yoshinobu Miyatsu, Masahiro Sakaguchi, Kazunari Yagi
  • Publication number: 20030027991
    Abstract: A method for converting a multimer of human serum albumin into monomers thereof comprises the step of treating the multimer with an alkaline solution. This method permits the efficient and quite simple conversion of human serum albumin multimers into monomers thereof at a low cost.
    Type: Application
    Filed: June 21, 2002
    Publication date: February 6, 2003
    Applicant: Juridical Fdn. The Chemo-Sero-Therap. Res. Ctr.
    Inventors: Toshinobu Nouchi, Hiroshi Mizokami, Yoshitaka Tajima, Hiroyuki Yokote, Satoshi Adachi, Yoshinobu Miyatsu, Tetsuro Tanabe, Yoshitaka Ushio, Shinichi Shibata
  • Publication number: 20020183492
    Abstract: Multimers of human serum albumin are removed from a solution of human serum albumin containing the multimers by bringing the human serum albumin solution into contact with an anion-exchanger equilibrated with a buffer containing a salt in a concentration ranging from 10 to 150 mM and having a pH value ranging from 5 to 9.5.
    Type: Application
    Filed: June 20, 2002
    Publication date: December 5, 2002
    Applicant: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Satoshi Adachi, Hiroshi Mizokami, Yoshitaka Tajima, Yoshinobu Miyatsu, Toshinobu Nouchi, Yoshitaka Ushio
  • Publication number: 20020182680
    Abstract: A method for preparing human serum albumin comprises the step of heat-treating a human serum albumin solution containing contaminants at a pH value in the proximity to the isoelectric point of the contaminants.
    Type: Application
    Filed: June 20, 2002
    Publication date: December 5, 2002
    Applicant: Juridical Fdn. The Chemo-Sero-Therap. Res. Ctr.
    Inventors: Toshinobu Nouchi, Hiroshi Mizokami, Yoshitaka Tajima, Yoshinobu Miyatsu, Masahiro Sakaguchi, Kazunari Yagi
  • Patent number: 5824552
    Abstract: A method is disclosed for culturing animal cells in a medium characterized n that said medium contains a compound represented by the general formula ##STR1## wherein, R denotes COOM or CHO, herein M denotes hydrogen, an alkali metal or a C.sub.1 to C.sub.3 alkyl group, and n is an integer of 1 to 3.According to the present method, proliferation of animal cells can be enhanced with good reproducibility.
    Type: Grant
    Filed: August 15, 1996
    Date of Patent: October 20, 1998
    Assignees: Teijin Limited, Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Yoshiharu Takazawa, Takami Arai, Masamichi Motoki, Kenji Nagura, Seiichi Yokoyama, Yoshinobu Miyatsu, Hiroshi Mizokami